References
- EMCDDA. (2014). European drug report: Trends and developments. Lisbon: Luxembourg: Publications Office of the European Union
- EMCDDA, & Europol. (2016). EU drug markets report: In-depth analysis. Luxembourg: Publications Office of the European Union
- European Commission. (2014). Flash Eurobarometer 401: Young people and drugs. Retrieved Jul 1, 2016, from http://ec.europa.eu/public_opinion/archives/flash_arch_404_391_en.htm
- Fattore, L., & Fratta, W. (2011). Beyond THC: The new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience, 5, 60. doi:10.3389/fnbeh.2011.00060
- Health Research Board. (2015). 2013 figures from the National Drug-Related Deaths Index. Retrieved from http://www.hrb.ie/uploads/tx_hrbpublications/NDRDI_web_update_2004-2013.pdf
- Home Office. (2014a). New psychoactive substances in England: A review of the evidence. Retrieved from https://www.gov.uk/government/publications/new-psychoactive-substances-in-england-a-review-of-the-evidence
- Home Office. (2014b). New psychoactive substances review: Report of the expert panel. Retrieved from https://www.gov.uk/government/publications/new-psychoactive-substances-review-report-of-the-expert-panel
- Hughes, B., & Winstock, A.R. (2012). Controlling new drugs under marketing regulations. Addiction, 107, 1894–1899. doi:10.1111/j.1360-0443.2011.03620.x
- Kavanagh, P.V., & Power, J.D. (2014). New psychoactive substances legislation in Ireland - perspectives from academia. Drug Testing and Analysis, 6, 884–891. doi:10.1002/dta.1598
- Reuter, P., & Pardo, B. (2016). Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill. Addiction, 112, 25–31. doi:10.1111/add.13439
- Schmidt, M.M., Sharma, A., Schifano, F., & Feinmann, C. (2011). “Legal highs” on the net—Evaluation of UK-based Websites, products and product information. Forensic Science International, 206, 92–97. doi:10.1016/j.forsciint.2010.06.030
- Seddon, T. (2014). Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS). International Journal of Drug Policy, 25, 1019–1024. doi:10.1016/j.drugpo.2014.03.009
- Smith, S.W., & Garlich, F.M. (2013). Availability and supply of novel psychoactive substances. In P. Dargan, & D. Wood (Eds.), Novel psychoactive substances: Classification, pharmacology and toxicology (pp. 55–77). London: Academic Press
- Smyth, B.P., James, P., Cullen, W., & Darker, C. (2015). “So prohibition can work?” Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban. International Journal of Drug Policy, 26, 887–889. doi:10.1016/j.drugpo.2015.05.021
- Stevens, A., Fortson, R., Measham, F., & Sumnall, H. (2015). Legally flawed, scientifically problematic, potentially harmful: The UK Psychoactive Substance Bill. International Journal of Drug Policy, 26, 1167–1170. doi:10.1016/j.drugpo.2015.10.005
- UK Government. (2016). Psychoactive Substances Act. Retrieved from http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted